In October 2012, the American Society of Reproductive Medicine announced it no longer considers oocyte freezing experimental. This raises complex questions about how to counsel patients who wish to preserve eggs for social indications.

In a randomized study of 249 women treated for urge incontinence, Botulinum toxin A (Botox) reduced episodes from an average of 5 per day to 3.3 per day, equal to standard anticholinergic treatment.

“Using a prophylactic sling during prolapse repair significantly reduces postoperative stress incontinence,” said Anthony Visco, a representative of the American Urogynecologic Society at the 61st annual American Congress of Obstetricians and Gynecologists meeting.

Diana Bianchi discusses noninvasive prenatal testing, including false positives and testing average-risk women, at ACOG's Annual Meeting.

Many ob/gyns and nurse practitioners see vulvovaginal disease on a day-to-day-basis, but lack the knowledge to accurately diagnose and treat them. At ACOG’s 61st Annual Clinical Meeting, Hope Haefner, MD, Department of Obstetrics and Gynecology at the University of Michigan, and Lynette Margesson, MD, Adjunct Assistant Professor of Obstetrics and Gynecology and Surgery (Dermatology) at the Geisel School of Medicine at Dartmouth, presented tips to help clinicians identify common and rare vulvar diseases.

Hormones, particularly transdermal estradiol, may help women maintain mood, cognition and memory in middle-age and beyond. “What we have learned the past decade is that not all estrogens are the same,” said ACOG presenter Sarah Berga, MD, of Women’s Health at Wake Forrest School of Medicine, “and that the differences can be critical.”

One in seven women will experience pelvic pain in her lifetime, and between one- and two-thirds will have chronic pain that persists for more than three years. But although it’s common, it can be one of the most difficult and frustrating conditions physicians treat.

There is a prevalence of ileocecal involvement (IC) in women with deep, infiltrating endometriosis (DIE) according to the study presented at AAGL.

A study to determine the prevalence rate of endometriosis in Hispanic women found that endometriosis may be under diagnosed due to failure to biopsy suspected lesions at the time of surgery and failure to accurately dictate and thoroughly describe operative findings in OpNote.

A systematic review of literature found that NovaSure® procedures resulted in high patient satisfaction, high rates of amenorrhea and low reintervention rates.

Preoperative measurement of intra-abdominal visceral fat, and the ratio of intra-abdominal visceral fat to subcutaneous fat, may help predict women at greater risk for difficulties during robotic surgery.

The use of NovaSure for endometrial ablation results a variety of poor pregnancy outcomes, according to a study presented by Shannon Smith, MD, at the Global Congress of the American Association of Gynecologic Laparoscopists.

Although operative time is longer as compared with laparotomy, minimally invasive hysterectomy in obese patients is safe, with less blood loss and shorter hospital stays.

While the cervical stump may serve as a tissue barrier for a patient who has undergone a laparoscopic sacrocervicopexy for organ prolapse, mesh erosion and bacterial infection can still occur.

In obese patients, laparoscopic ports should be placed more than 10 centimeters from the midline to minimize the chance of injury to epigastric vessels, according to research presented at the 41st Global Congress of the American Association of Gynecologic Laparoscopists.

Radiofrequency volumetric thermal ablation is a safe and effective treatment for menorrhagia in women with symptomatic fibroids, providing both clinically and statistically significant reduction in blood loss, according to new research.

More than 64% of the adult women in the United States are overweight or obese, and these patients pose special challenges for surgeons. New research examining outcomes and complication rates, particularly in the emerging field of robotic surgery, will allow better management of these patients, and ObGyn.net will be paying special attention to this research at AAGL 2012 in Las Vegas.

ObGyn.net is headed to AAGL 2012 in Las Vegas, and we want to know: Which plenary sessions interest you most?

With AAGL 2012 right around the corner, we’re looking back at some of the most popular articles to come out previous AAGL meetings.